Chiron Real Estate (XRN) Fundamental Analysis: Bull vs. Bear Case

XRN

Chiron Real Estate

Fundamental data last updated:April 13, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Real Estate

industry

REIT - Healthcare Facilities

Exchange

NYSE

County of HQ

United States

Next Earnings Date

05/06/26

Business Summary

Chiron Real Estate operates as a healthcare-focused REIT, acquiring and leasing healthcare facilities to generate rental income. The model is straightforward: acquire properties, lease them under contractual agreements, and distribute cash flows to shareholders. The moat, when functioning properly, comes from long-duration leases, specialized healthcare tenancy, and embedded switching costs tied to facility location and regulatory approvals. Cash generation depends on occupancy stability and disciplined balance sheet management, which are critical in a capital-intensive real estate structure.

VALUATION

P/E

-

Market Cap ($M USD)

$472

Forward P/E

-

PEG

-

PRICE TO SALES

3.2 PRICE TO BOOK

1.2 EV / EBITDA

14.9 5-Year Average P/E

Free Cash Flow Yield

DCF Value

Graham Number

Price to FCF

EV to FCF

Earnings Yield

FCF Yield

DIVIDEND

Yield

15.40%

Annual Payout

$3.00

Payout Ratio

-

Consecutive Years of Dividend Growth

0 5-Year Dividend Growth Rate

-24.60%

Financial Health & Profitability

Earnings Per Share

-$0.91

Next Year EPS Growth Estimate

-$0.61

Next Year Revenue Growth Estimate

2.00%

Return on Equity (ROE)

-2.40%

FREE CASH FLOW

Operating Margin

24.40%

Debt-to-Equity

1.3 Piotroski F-Score

5 Altman Z-Score

-0.4

Return on Invested Capital (ROIC)

1.80%

Current Ratio

0 Quick Ratio

Net Debt to EBITDA

Interest Coverage

Gross Profit margin

FCF PER SHARE

REVENUE PER SHARE

Gainseekers Quantitative Analysis

Summary

At a $472M market cap, XRN screens optically cheap on Price/Book at 1.2 and Price/Sales at 3.2, but this is not a clean value story. Forward P/E is nonexistent and EPS Next Year is projected at -$0.91, signaling an earnings collapse from the current 14.9, while the Altman Z-Score of -0.4 is deep in distress territory. Operating Margin of -2.40% and ROIC of 1.80% confirm weak capital efficiency, and a Current Ratio of 0 adds liquidity concern. This is not a mispricing driven by temporary pessimism—it’s a balance sheet and forward earnings credibility issue, and the market is pricing in fragility rather than growth.

AI Exposure / Tech Reliance

As a REIT focused on healthcare facilities, XRN’s AI exposure is indirect but potentially durable, since healthcare real estate demand tends to be structurally sticky. Technology adoption in healthcare can increase tenant viability, but it does not materially change the landlord economics. The company’s resilience to AI disruption is moderate because physical healthcare infrastructure remains necessary regardless of digital transformation.

The Bull Case

A value-oriented investor could argue that a 1.2 Price/Book in healthcare real estate offers asset-backed downside support, particularly with a Piotroski F-Score of 5 suggesting middling but not collapsing fundamentals. Return on Equity at 2.00% and ROIC at 1.80% are positive, if thin, indicating the business is at least generating returns above zero. Institutional Ownership at $41.28 implies some professional sponsorship, and a TTM Yield of 1.3 combined with a Dividend Per Share of 15.40% may attract income-focused capital if sustainable. In a stabilized scenario, modest profitability plus asset backing could offer asymmetric upside from a depressed sentiment base.

The Bear Case

The bear case is significantly stronger: EPS is expected to swing to -$0.91 next year, Sales Growth Next Year is -$0.61, and Operating Margin is already negative at -2.40%, pointing to deteriorating core performance. Debt/Equity at 24.40% layered onto an Altman Z-Score of -0.4 and a Current Ratio of 0 is a flashing solvency warning. The lack of a Forward P/E and PEG Forward underscores the absence of visible growth, while a Short % of Float at -24.60% reflects heavy positioning against the stock. Add a Payout Ratio of $3.00 with declining earnings power, and dividend sustainability becomes a legitimate structural risk.

Market Sentiment & Smart Money

Short Interest %

4.80%

Analyst Consensus

2.13 Average Analyst Price Target

$41.28

Institutional Ownership %

69.00%

1-Year Beta

0.53 Insider Buying % (6 Mo)

6.10%%

Distance to 52-Week High

89.40%

Distance to 52-Week Low

122.80%

EARNINGS SURPRISE %

50-DAY SMA

200-DAY SMA

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.